Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response-Reference-Cited by-同舟云学术

Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response

Published:2000 Issue:1 Volume:6 Page:1-7
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Tateda Kazuhiro,Ishii Yoshikazu,Matsumoto Tetsuya,Kobayashi Takao,Miyazaki Shuichi,Yamaguchi Keizo

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Link

http://www.springerlink.com/index/pdf/10.1007/s101560050042

Reference26 articles.

1. The role of Pseudomonas aeruginosa in infections;Neu;J Antimicrob Chemother,1983

2. Cystic fibrosis;Wood;Am Rev Respir Dis,1976

3. Diffuse panbronchiolitis: a disease of the transitional zone of the lung;Homma;Chest,1983

4. Airway biofilm disease: clinical manifestations and therapeutic possibilities using macrolides;Kobayashi;J Infect Chemother,1995

5. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis (in Japanese with English abstract);Kudoh;Jpn J Thorac Dis,1987

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Milk-Derived Enterococcus faecalis HM20: A Potential Alternative Agent of Antimicrobial Effect against Methicillin-Resistant Staphylococcus aureus (MRSA);Microorganisms;2024-01-31

2. Macrolides and Cystic Fibrosis;Progress in Inflammation Research;2024

3. Antimicrobial and Antibiofilm Effect of Bacteriocin-Producing Pediococcus inopinatus K35 Isolated from Kimchi against Multidrug-Resistant Pseudomonas aeruginosa;Antibiotics;2023-03-30

4. Therapeutic Potential of an Azithromycin-Colistin Combination against XDR K. pneumoniae in a 3D Collagen-Based In Vitro Wound Model of a Biofilm Infection;Antibiotics;2023-02-01

5. New antimicrobial peptide-antibiotic combination strategy for Pseudomonas aeruginosa inactivation;Biointerphases;2022-07